Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

bempedoic acid

- PMLiVE

Testing antibodies in blood samples could help prevent heart attacks

People with serious atherosclerosis are more likely to have a serious heart or circulatory problem

- PMLiVE

Esperion’s heart drug shown to reduce risk of major adverse cardiovascular events

Cardiovascular diseases result in an estimated 17.9 million deaths each year

- PMLiVE

Esperion gets FDA thumbs up for cholesterol drug Nexletol

Big comeback after previous trial fail

- PMLiVE

Esperion craters as deaths mar atherosclerosis drug study

But the company insists its atherosclerosis candidate didn’t cause the deaths

- PMLiVE

Lilly drops evacetrapib on failed atherosclerosis trial

Leaves hole in company's late-stage pipeline

- PMLiVE

AZ in atherosclerosis education drive during US Heart Month

Encouraging the public to learn more about the causes of heart disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links